UB-165: A Novel Nicotinic Agonist with Subtype Selectivity Implicates the α4β2* Subtype in the Modulation of Dopamine Release from Rat Striatal Synaptosomes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Presynaptic nicotinic acetylcholine receptors (nAChRs) on striatal synaptosomes stimulate dopamine release. Partial inhibition by the α3β2-selective α-conotoxin-MII indicates heterogeneity of presynaptic nAChRs on dopamine terminals. We have used this α-conotoxin and UB-165, a novel hybrid of epibatidine and anatoxin-a, to address the hypothesis that the α-conotoxin-MII-insensitive subtype is composed of α4 and β2 subunits. UB-165 shows intermediate potency, compared with the parent molecules, at α4β2* and α3-containing binding sites, and resembles epibatidine in its high discrimination of these sites over α7-type and muscle binding sites. (±)-Epibatidine, (±)-anatoxin-a, and (±)-UB-165 stimulated [3 H]-dopamine release from striatal synaptosomes with EC 50 values of 2.4, 134, and 88 n m, and relative efficacies of 1:0.4:0.2, respectively. α-Conotoxin-MII inhibited release evoked by these agonists by 48, 56, and 88%, respectively, suggesting that (±)-UB-165 is a very poor agonist at the α-conotoxin-MII-insensitive nAChR subtype. In assays of 86 Rb+efflux from thalamic synaptosomes, a model of an α4β2* nAChR response, (±)-UB-165 was a very weak partial agonist; the low efficacy of (±)-UB-165 at α4β2 nAChR was confirmed in Xenopus oocytes expressing various combinations of human nAChR subunits. In contrast, (±)-UB-165 and (±)-anatoxin-a were similarly efficacious and similarly sensitive to α-conotoxin-MII in increasing intracellular Ca 2+in SH-SY5Y cells, a functional assay for native α3-containing nAChR. These data support the involvement of α4β2* nAChR in the presynaptic modulation of striatal dopamine release and illustrate the utility of exploiting a novel partial agonist, together with a selective antagonist, to dissect the functional roles of nAChR subtypes in the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922 · cited 1×
“Ki values were derived from IC50 values according to the method of Cheng and Prusoff (1973), assuming Kd values of 10 and 1 nM for [ 3H]-nicotine and [ 125I]-aBgt binding to rat brain membranes and 0.12 nM for [ 125I]aBgt binding to rat muscle, respectively.”
MethodInfluentialPolazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · cited 4×
“Neurons in the substantia nigra pars compacta of the rat express mRNA for a3, a4, a5, a6, b2, and b3 (Wonnacott, 1997) and possibly b4 and a7 subunits (Charpantier et al., 1998), and some or all of these may contribute to nAChRs on dopaminergic terminals in the striatum.”
BackgroundInfluentialSelf-citationWada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044 · cited 1×
“6), but the lack of expression of a2 in substantia nigra (Wada et al., 1989) excludes this as a contributor to the presynaptic modulation of striatal dopamine release.”
BackgroundNicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762 · cited 2×
“Instead, their primary function may be modulatory (Role and Berg, 1996).”
BackgroundMolecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605
Lukas, R. J., Changeux, J.-P., le Novère, N., Albuquerque, E. X., Balfour, D. J. K., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B. S., Collins, A. C., et al. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01406-6 · Cited by 537
Self-citationClarke, P. B. S., & Pert, A. (1985) · Brain Research · doi:10.1016/0006-8993(85)90456-1 · Cited by 527 · cited 1×
“Copyright © 2000 Society for Neuroscience 0270-6474/00/202783-09$15.00/0 dopamine lesion of the nigrostriatal pathway is consistent with a4b2 nAChRs on striatal terminals (Clarke and Pert, 1985).”
BackgroundInfluentialA New α-Conotoxin Which Targets α3β2 Nicotinic Acetylcholine Receptors
Cartier, G. E., Yoshikami, D., Gray, W. R., Luo, S., Olivera, B. M., & McIntosh, J. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7522 · Cited by 489 · cited 6×
“Racemic UB-165 (Wright et al., 1997) and a-conotoxin-MII (Cartier et al., 1996; Kaiser et al., 1998) were synthesized as previously described.”
BackgroundMethodInfluentialNeuronal Nicotinic Acetylcholine Receptors as Targets for Drug Discovery
Holladay, M. W., Dart, M. J., & Lynch, J. K. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970377o · Cited by 444 · cited 4×
“…has been exploited as a model system for examining native nAChR responses (Soliakov and Wonnacott, 1996; Grady et al., 1997) and evaluating novel ligands (Holladay et al., 1997) and is pertinent to physiological and pathological processes (Dani and Heinemann, 1996; Decker and Arneric, 1998).”
BackgroundInfluentialChavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · PubMed · Cited by 392
Self-citationIdentification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387
Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385 · cited 1×
“The restricted distributions of a6 and b3 mRNA in the CNS, with high expression in the substantia nigra pars compacta (Deneris et al., 1989; Le Novère et al., 1996; Charpantier et al., 1998), together with the erstwhile “orphan” status of the a6 and b3 subunits, makes them prime candidates for…”
BackgroundGrady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350 · cited 3×
“Insensitivity to the a7-selective antagonists a-bungarotoxin (aBgt) (Rapier et al., 1990; Grady et al., 1992) and a-conotoxin-ImI (Kulak et al., 1997) argues against the direct involvement of a7 nAChR.”
BackgroundSelf-citationAssembly of Human Neuronal Nicotinic Receptor α5 Subunits with α3, β2, and β4 Subunits
Wang, F., Gerzanich, V., Wells, G. B., Anand, R., Peng, X., Keyser, K., & Lindstrom, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17656 · Cited by 345 · cited 3×
“[ 3H]-Epibatidine labels a3-containing nAChRs in human neuroblastoma SH-SY5Y cells (Wang et al., 1996).”
BackgroundMethodInfluentialIdentification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J.-P. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 343 · cited 1×
“Most high-affinity [3H]-nicotine binding sites in rat brain are considered to represent the a4b2 subtype (Zoli et al., 1998).”
BackgroundFrazier, C. J., Buhler, A. V., Weiner, J. L., & Dunwiddie, T. V. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08228.1998 · Cited by 327 · cited 1×
“With a few recently reported exceptions (Alkondon et al., 1998; Frazier et al., 1998), most nAChRs in the brain do not appear to mediate synaptic transmission.”
BackgroundConus Peptides Targeted to Specific Nicotinic Acetylcholine Receptor Subtypes
McIntosh, J. M., Santos, A. D., & Olivera, B. M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.59 · Cited by 295 · cited 1×
“A recent advance has been the identification of Conus toxins that target particular neuronal nAChR subtypes (McIntosh et al., 1999). a-Conotoxin-MII, with specificity for a3b2-containing nAChRs (Cartier et al., 1996), partially inhibits the nicotinic stimulation of [3H]-dopamine release from…”
BackgroundAlkondon, M., Pereira, E. F. R., & Albuquerque, E. X. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00880-4 · Cited by 263 · cited 1×
“With a few recently reported exceptions (Alkondon et al., 1998; Frazier et al., 1998), most nAChRs in the brain do not appear to mediate synaptic transmission.”
BackgroundDavies, A. R. L., Hardick, D. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., & Wonnacott, S. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00221-4 · Cited by 247 · cited 2×
“P2 membranes (250 mg protein) were incubated in a total volume of 250 ml in 50 mM phosphate buffer with 1 nM [ 125I]-aBgt and serial dilutions of test drugs (Davies et al., 1999).”
MethodSelf-citationβ3: A New Member of Nicotinic Acetylcholine Receptor Gene Family Is Expressed in Brain
Deneris, E. S., Boulter, J., Swanson, L. W., Patrick, J., & Heinemann, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83343-9 · Cited by 225 · cited 1×
“The restricted distributions of a6 and b3 mRNA in the CNS, with high expression in the substantia nigra pars compacta (Deneris et al., 1989; Le Novère et al., 1996; Charpantier et al., 1998), together with the erstwhile “orphan” status of the a6 and b3 subunits, makes them prime candidates for…”
BackgroundPeng, X., Katz, M., Gerzanich, V, Anand, R., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10029-1 · Cited by 222 · cited 1×
“SH-SY5Y cells expresses mRNA for a3, a5, a7, b2, and b4 nAChR subunits (Lukas et al., 1993; Peng et al., 1994).”
BackgroundChavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36376-1 · Cited by 207
Self-citationFenster, C. P., Whitworth, T. L., Sheffield, E. B., Quick, M. W., & Lester, R. A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-04804.1999 · Cited by 204 · cited 1×
“Together with the general inability of antagonists to prevent agonist-induced upregulation, a higher affinity state of the nAChRs than the active conformation is implicated as the trigger for the upregulation of binding sites (Whiteaker et al., 1998; Fenster et al., 1999).”
Backgroundα-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes
Kulak, J. M., Nguyen, T. A., Olivera, B. M., & McIntosh, J. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05263.1997 · Cited by 200 · cited 12×
“These disparate views are reconciled by the nAChR heterogeneity implicit in the partial inhibition by a-conotoxin-MII (Kulak et al., 1997; Kaiser et al., 1998).”
BackgroundInfluentialRapier, C., Lunt, G. G., & Wonnacott, S. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02341.x · Cited by 196 · cited 1×
“Insensitivity to the a7-selective antagonists a-bungarotoxin (aBgt) (Rapier et al., 1990; Grady et al., 1992) and a-conotoxin-ImI (Kulak et al., 1997) argues against the direct involvement of a7 nAChR.”
BackgroundSelf-citationLukas, R. J., Norman, S. A., & Lucero, L. (1993) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1993.1001 · Cited by 192 · cited 1×
“SH-SY5Y cells expresses mRNA for a3, a5, a7, b2, and b4 nAChR subunits (Lukas et al., 1993; Peng et al., 1994).”
BackgroundCharpantier, E., Barnéoud, P., Moser, P., Besnard, F., & Sgard, F. (1998) · NeuroReport · doi:10.1097/00001756-199809140-00033 · Cited by 164 · cited 2×
“Neurons in the substantia nigra pars compacta of the rat express mRNA for a3, a4, a5, a6, b2, and b3 (Wonnacott, 1997) and possibly b4 and a7 subunits (Charpantier et al., 1998), and some or all of these may contribute to nAChRs on dopaminergic terminals in the striatum.”
BackgroundKaiser, S. A., Soliakov, L., Harvey, S. C., Luetje, C. W., & Wonnacott, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70031069.x · Cited by 160
Self-citationWhiteaker, P., Sharples, C. G. V., & Wonnacott, S. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13263-4 · Cited by 152
Self-citationBindingDB (2012) · PubMed · doi:10.7270/q2b856pt · Cited by 147
Sacaan, A. I., Dunlop, J. L., & Lloyd, G. K. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10508-9 · Cited by 127 · cited 1×
“…dopamine release from rodent striatal synaptosomes and slices in a concentration-dependant manner, and this response is blocked by nicotinic antagonists, including mecamylamine and dihydroberythroidine (Grady et al., 1992; El-Bizri and Clarke, 1994; Sacaan et al., 1995; Soliakov et al., 1995).”
BackgroundMarks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J., & Collins, A. C. (1999) · PubMed · Cited by 126
Self-citationMarks, M. J., Farnham, D. A., Grady, S. R., & Collins, A. C. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10175-4 · Cited by 112 · cited 4×
“P2 synaptosomes from mouse (A, B) or rat (C) thalamus were loaded with (86)Rb 1 and superfused; (86)Rb 1 efflux is a measure of nAChR activation, primarily of the a4b2 subtype (Marks et al., 1993).”
BackgroundMethodInfluentialSelf-citationElliott, K. J., Ellis, S. B., Berckhan, K. J., Urrutia, A., Chavez-Noriega, L. E., Johnson, E. C., Veliçelebi, G., & Harpold, M. M. (1996) · Journal of Molecular Neuroscience · doi:10.1007/bf02736842 · Cited by 101
Soliakov, L., & Wonnacott, S. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010163.x · Cited by 101
Self-citationGroot-Kormelink, P. J., Luyten, W. H. M. L., Colquhoun, D., & Sivilotti, L. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15317 · Cited by 100 · cited 2×
“…compacta (Deneris et al., 1989; Le Novère et al., 1996; Charpantier et al., 1998), together with the erstwhile “orphan” status of the a6 and b3 subunits, makes them prime candidates for complex combinations with other subunits such as a3 and b2 (Fucile et al., 1998; Groot-Kormelink et al., 1998).”
BackgroundAlkondon, M., & Albuquerque, E. X. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10528-4 · Cited by 88 · cited 1×
“…show different efficacies with different agonists, with the ratio 1:0.6:0.3 for (1)-epibatidine, (2)-nicotine, and (1)-anatoxin-a, respectively (Alkondon and Albuquerque, 1995), similar to those found here for these agonists, with respect to a-conotoxin-MII-insensitive [3H]-dopamine release…”
BackgroundInfluentialAnatoxin-a-evoked [3H]dopamine release from rat striatal synaptosomes
Soliakov, L. S., Gallagher, T. C., & Wonnacott, S. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00122-m · Cited by 82 · cited 4×
“P2 synaptosomes were prepared from mouse or rat thalamus by homogenization in 0.32 M sucrose in 5 mM HEPES, pH 7.5, and differential centrifugation (Soliakov et al., 1995).”
BackgroundMethodInfluentialSelf-citationEl‐Bizri, H., & Clarke, P. B. S. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14749.x · Cited by 80
Marks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J.-P., & Collins, A. C. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38240-0 · Cited by 79 · cited 1×
“86Rb1 efflux from thalamic synaptosomes The efflux of 86Rb1 from preloaded mouse thalamic synaptosomes in response to nicotinic agonists is proposed to reflect the activation of a4b2 nAChRs (Marks et al., 1993, 1996, 1999).”
BackgroundSelf-citationFucile, S., Matter, J., Erkman, L., Ragozzino, D., Barabino, B., Grassi, F., Alemà, S., Ballivet, M., & Eusebi, F. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00001.x · Cited by 68 · cited 1×
“…compacta (Deneris et al., 1989; Le Novère et al., 1996; Charpantier et al., 1998), together with the erstwhile “orphan” status of the a6 and b3 subunits, makes them prime candidates for complex combinations with other subunits such as a3 and b2 (Fucile et al., 1998; Groot-Kormelink et al., 1998).”
BackgroundMarks, M. J., Robinson, S. F., & Collins, A. C. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13086-3 · Cited by 65 · cited 6×
“5A), as reported previously (Marks et al., 1996), (6)-UB-165 produced very little response when tested over the concentration range examined in the [3H]-dopamine release assay (Fig.”
BackgroundMethodInfluentialSelf-citationGrady, S. R., Grun, E. U., Marks, M. J., & Collins, A. C. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36799-0 · Cited by 65 · cited 1×
“…release from striatal preparations has been exploited as a model system for examining native nAChR responses (Soliakov and Wonnacott, 1996; Grady et al., 1997) and evaluating novel ligands (Holladay et al., 1997) and is pertinent to physiological and pathological processes (Dani and…”
MethodSelf-citationSynthesis of UB-165: A novel nicotinic ligand and anatoxin-a/epibatidine hybrid
Wright, E., Gallagher, T. C., Sharples, C. G. V., & Wonnacott, S. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(97)10090-7 · Cited by 62 · cited 6×
“Racemic UB-165 (Wright et al., 1997) and a-conotoxin-MII (Cartier et al., 1996; Kaiser et al., 1998) were synthesized as previously described.”
BackgroundMethodInfluentialSelf-citationBencherif, M., Schmitt, J. D., Bhatti, B. S., Crooks, P. A., Caldwell, W. S., Lovette, M. E., Fowler, K., Reeves, L., & Lippiello, P. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37321-5 · Cited by 50 · cited 1×
“For example RJR 2429 has a structure comparable to UB-165, comprising an azobicyclo[2.2.2]octane core coupled to a chloropyridyl moiety (Bencherif et al., 1998), and has a profile similar to UB-165 in functional and binding assays, except for its much higher potency at muscle nAChRs.”
BackgroundInfluentialPurification of L-[3H] nicotine eliminates low affinity binding
Romm, E., Lippiello, P. M., Marks, M. J., & Collins, A. C. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90095-9 · Cited by 38 · cited 3×
“P2 membranes (250 mg protein) were incubated in a total volume of 250 ml in HEPES buffer (20 mM HEPES, pH 7.4, containing 118 mM NaCl, 4.8 mM KCl, 2.5 mM CaCl2, 200 mM Tris, 0.1 mM PMSF, 0.01% (w/v) NaN3) (Romm et al., 1990) with 10 nM (2)-[ 3H]-nicotine and serial dilutions of test drugs.”
MethodInfluentialSelf-citationGarcha, H. S., Thomas, P., Spivak, C. E., Wonnacott, S., & Stolerman, I. P. (1993) · Psychopharmacology · doi:10.1007/bf02251292 · Cited by 13
Self-citation
Cited by
Klink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
“Functional studies have focused on the pharmacology of dopamine release in striatal synaptosomes and slices [Sharples et al. (2000) and references therein].”
BackgroundNicotinic acetylcholine receptors: from structure to brain function
Hogg, R. C., Raggenbass, M., & Bertrand, D. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0005-1 · Cited by 528
Champtiaux, N., Gotti, C., Cordero-Erausquin, M., David, D. J., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F. M., Le Novère, N., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 507
Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08785.2002 · Cited by 407
“, 1992), and UB-165 (Sharples et al., 2000) on striatal synaptosomal preparations, it was suggested that both 4* and (non 4)* nAChRs mediate DA release in striatum.”
BackgroundChronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function
Buisson, B., & Bertrand, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01819.2001 · Cited by 361
“In the striatum, the modulation of dopamine release depends on a4b2 nAChRs (Sharples et al., 2000).”
Background
Metadata
- Authors
- Sharples, C. G. V., Kaiser, S., Soliakov, L., Marks, M. J., Collins, A. C., Washburn, M., Wright, E., Spencer, J. A., Gallagher, T., Whiteaker, P., & Wonnacott, S.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2000-04-15
- Volume
- 20
- Issue
- 8
- Pages
- 2783-2791
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1908660545
- Cited by
- 166
- References
- 49
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.